Feed LAURUSLABS.NS
LA
Laurus Labs Limited
LAURUSLABS.NS · NSE
₹1,845.00 +0.04% (+₹0.70)
1M +18.33%
Market Cap ₹1.0T
P/E Ratio 91.60x
Div. Yield -
ROE 22.80%
Bulios Fair Price
₹1,436
22.2% downside
Preț actual
₹1,845
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile LAURUSLABS.NS sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
13 /100
Expensive EV/EBITDA 49.41x
P/S 13.78x
P/B 18.90x
Growth
58 /100
Stable Rev. growth 4.09%
FCF growth 370.46%
Book val. growth 9.49%
Profitability
64 /100
Moderate Net margin 15.04%
Op. margin 21.28%
FCF margin 0.00%
Quality
81 /100
Excellent ROE 22.80%
ROA 10.40%
Asset turnover 0.69x
Debt
81 /100
Low Current ratio 1.33x
Int. coverage 9.84x
Net debt/EBITDA 1.16x
Stability
46 /100
Moderate Rev. volatility 20.04%
EPS volatility 124.93%
Profitable years 6
Întreabă StockBot despre LAURUSLABS.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Satyanarayana Chava
Employees
7,059
Headquarters
Hyderabad
Evenimente viitoare
22 OCT.
Earnings
Upcoming earnings report